S.A. Johnson

2.6k total citations
35 papers, 2.0k citations indexed

About

S.A. Johnson is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, S.A. Johnson has authored 35 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 13 papers in Hematology and 12 papers in Oncology. Recurrent topics in S.A. Johnson's work include Chronic Lymphocytic Leukemia Research (12 papers), Acute Myeloid Leukemia Research (10 papers) and Acute Lymphoblastic Leukemia research (7 papers). S.A. Johnson is often cited by papers focused on Chronic Lymphocytic Leukemia Research (12 papers), Acute Myeloid Leukemia Research (10 papers) and Acute Lymphoblastic Leukemia research (7 papers). S.A. Johnson collaborates with scholars based in United Kingdom, United States and France. S.A. Johnson's co-authors include John C. Cambier, Lily Pao, Marcus R. Clark, Alex Smith, P.J. Wyld, Wolfgang Hiddemann, Gunnar Juliusson, H. Löffler, Bertold Emmerich and Deborah Richardson and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

S.A. Johnson

35 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.A. Johnson United Kingdom 21 774 716 587 456 425 35 2.0k
Eugenio Gallo Italy 27 393 0.5× 489 0.7× 428 0.7× 548 1.2× 711 1.7× 94 2.3k
Manuel E. Kaplan United States 25 944 1.2× 473 0.7× 562 1.0× 387 0.8× 786 1.8× 53 2.3k
Michael Doubek Czechia 23 984 1.3× 510 0.7× 676 1.2× 519 1.1× 702 1.7× 169 2.3k
Ewa Lech‐Marańda Poland 25 511 0.7× 437 0.6× 479 0.8× 421 0.9× 414 1.0× 134 1.7k
C. Darrell Jennings United States 20 257 0.3× 602 0.8× 278 0.5× 299 0.7× 707 1.7× 58 1.8k
KB McCredie United States 26 1.2k 1.5× 561 0.8× 421 0.7× 648 1.4× 1.7k 3.9× 60 2.8k
Bertold Emmerich Germany 32 1.7k 2.2× 1.2k 1.6× 1.3k 2.3× 759 1.7× 916 2.2× 114 3.5k
M Keating United States 27 1.4k 1.9× 502 0.7× 974 1.7× 908 2.0× 991 2.3× 52 3.3k
LL Sensenbrenner United States 24 426 0.6× 525 0.7× 238 0.4× 500 1.1× 1.2k 2.9× 67 2.0k
Bradley T. Messmer United States 16 1.2k 1.5× 1.2k 1.6× 749 1.3× 222 0.5× 160 0.4× 41 2.1k

Countries citing papers authored by S.A. Johnson

Since Specialization
Citations

This map shows the geographic impact of S.A. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.A. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.A. Johnson more than expected).

Fields of papers citing papers by S.A. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.A. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.A. Johnson. The network helps show where S.A. Johnson may publish in the future.

Co-authorship network of co-authors of S.A. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of S.A. Johnson. A scholar is included among the top collaborators of S.A. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.A. Johnson. S.A. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, S.A., et al.. (2019). A CBC algorithm combined with immature platelet fraction is able to identify JAK2 V617F mutation‐positive polycythaemia vera patients. International Journal of Laboratory Hematology. 41(2). 271–276. 7 indexed citations
2.
Else, Monica, Claire Dearden, Estella Matutes, et al.. (2009). Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. British Journal of Haematology. 145(6). 733–740. 175 indexed citations
3.
Wang, Yanong D., Biqi Wu, S.A. Johnson, et al.. (2008). Synthesis, SAR study and biological evaluation of novel pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as anti-proliferative agents. Bioorganic & Medicinal Chemistry. 17(5). 2091–2100. 34 indexed citations
4.
Boschelli, Diane H., Yanong D. Wang, S.A. Johnson, et al.. (2004). 7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as Dual Inhibitors of Src and Abl Kinases. Journal of Medicinal Chemistry. 47(7). 1599–1601. 51 indexed citations
5.
Rossi, Jean François, Ambro van Hoof, K. De Boeck, et al.. (2004). Efficacy and Safety of Oral Fludarabine Phosphate in Previously Untreated Patients With Chronic Lymphocytic Leukemia. Journal of Clinical Oncology. 22(7). 1260–1267. 36 indexed citations
6.
Johnson, S.A., D. Oscier, & V. Leblond. (2002). Waldenström's macroglobulinaemia. Blood Reviews. 16(3). 175–184. 24 indexed citations
7.
8.
Savage, David G., T. J. Garrett, Wolfgang Oster, et al.. (2000). Gemcitabine for relapsed or resistant lymphoma. Annals of Oncology. 11(5). 595–598. 59 indexed citations
9.
Johnson, S.A., Daniel Catovsky, J. A. Child, et al.. (1998). Phase I/II evaluation of Pentostatin (2′-deoxycoformycin) in a five day schedule for the treatment of relapsed/refractory B-cell chronic lymphocytic leukaemia. Investigational New Drugs. 16(2). 155–160. 33 indexed citations
10.
Richardson, Deborah & S.A. Johnson. (1997). Anthracyclines in haematology: preclinical studies, toxicity and delivery systems. Blood Reviews. 11(4). 201–223. 76 indexed citations
11.
Johnson, S.A., Peter Harper, Gabriel N. Hortobágyi, & P Pouillart. (1996). Vinorelbine: an overview. Cancer Treatment Reviews. 22(2). 127–142. 96 indexed citations
12.
Kurosaki, Tomohiro, S.A. Johnson, Lily Pao, et al.. (1995). Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling.. The Journal of Experimental Medicine. 182(6). 1815–1823. 220 indexed citations
13.
Prentice, Archie, David W. Warnock, S.A. Johnson, M. J. Phillips, & Dominic Oliver. (1994). Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients. Journal of Antimicrobial Chemotherapy. 34(2). 247–252. 77 indexed citations
14.
Johnson, S.A., et al.. (1992). Esophagogastric Ring: Why and When We See It, and What It Implies: A Radiologic-Pathologic Correlation. Southern Medical Journal. 85(10). 946–952. 8 indexed citations
15.
Johnson, S.A., Archie Prentice, & M. J. Phillips. (1988). Treatment of Acute Myeloid Leukaemia with Early Intensive Induction Therapy. Acta Oncologica. 27(5). 527–529. 7 indexed citations
16.
Lister, Tim, S.A. Johnson, Richard Bell, Guylaine Henry, & J. S. Malpas. (1981). Progress in Acute Myeologenous Leukemia. Hämatologie und Bluttransfusion. 26. 38–44. 2 indexed citations
17.
Greaves, Melvyn F., et al.. (1980). Acute lymphoblastic leukaemia associated antigen. III Alterations in expression during treatment and in relapse. Leukemia Research. 4(1). 1–14. 75 indexed citations
18.
Brearley, Roger, S.A. Johnson, & T. Andrew Lister. (1979). Acute lymphoblastic leukaemia in adults: Clinicopathological correlations with the French-American-British (FAB) co-operative group classification. European Journal of Cancer (1965). 15(6). 909–914. 27 indexed citations
19.
Williams, Geraint T., S.A. Johnson, Paul Dieppe, & E.C. HUSKISSON. (1978). Neutropenia during treatment of rheumatoid arthritis with levamisole.. Annals of the Rheumatic Diseases. 37(4). 366–369. 19 indexed citations
20.
Johnson, S.A., Chris Bateman, M. E. J. Beard, J. M. A. Whitehouse, & A. H. Waters. (1977). Long-Term Haematological Complications of Thorotrast. QJM. 46(182). 259–71. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugenio Gallo Breakdown of academic impact, for papers by Manuel E. Kaplan Breakdown of academic impact, for papers by Michael Doubek Breakdown of academic impact, for papers by Ewa Lech‐Marańda Breakdown of academic impact, for papers by C. Darrell Jennings Breakdown of academic impact, for papers by KB McCredie Breakdown of academic impact, for papers by Bertold Emmerich Breakdown of academic impact, for papers by M Keating Breakdown of academic impact, for papers by LL Sensenbrenner Breakdown of academic impact, for papers by Bradley T. Messmer
Rankless by CCL
2026